A liposomal formulation for the oral application of the investigational hepatitis B drug Myrcludex B

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 103, Issue , 2016, Pages 159-166

  Uhl, P ^a,b   Helm, F ^a   Hofhaus, G ^a   Brings, S ^b   Kaufman, C ^b   Leotta, Karin ^b   Urban, S ^b   Haberkorn, U ^b   Mier, W ^b   Fricker, G ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Hepatitis B; Liposome; Myrcludex B; Oral delivery; Peptide drugs; Tetraether lipids

Indexed keywords

ANTIVIRUS AGENT; GLYCERYLCALDITYLTETRAETHER LIPID DERIVATIVE; IODINE 131; LIPOSOME; PEPTIDE DERIVATIVE; SUCROSE; TREHALOSE; UNCLASSIFIED DRUG; LIPOPEPTIDE; MYRCLUDEX-B;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG STABILITY; DRUG STORAGE; ENCAPSULATION; FREEZE DRYING; HEPATITIS B; NONHUMAN; PARTICLE SIZE; RAT; SOLID PHASE SYNTHESIS; SULFOLOBUS ACIDOCALDARIUS; ZETA POTENTIAL; ANIMAL; MALE; ORAL DRUG ADMINISTRATION; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTIVIRAL AGENTS; DRUG COMPOUNDING; HEPATITIS B; LIPOPEPTIDES; LIPOSOMES; MALE; RATS; RATS, WISTAR;

EID: 84962793786     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2016.03.031     Document Type: Article

References (33)

1. S.V. Sastry, J.R. Nyshadham, and J.A. Fix Recent technological advances in oral drug delivery - a review Pharm. Sci. Technol. Today 3 2000 138 145
2. H. Kwon, and A.S. Lok Hepatitis B therapy Nat. Rev. Gastroenterol. Hepatol. 8 2011 275 284
3. J.F. Perz, G.L. Armstrong, L.A. Farrington, Y.J. Hutin, and B.P. Bell The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide J. Hepatol. 45 2006 529 538
4. P. Uhl, G. Fricker, U. Haberkorn, and W. Mier Current status in the therapy of liver diseases Int. J. Mol. Sci. 15 2014 7500 7512
5. S. Urban, R. Bartenschlager, R. Kubitz, and F. Zoulim Strategies to inhibit entry of HBV and HDV into hepatocytes Gastroenterology 147 2014 48 64
6. T. Volz, L. Allweiss, M.B. MBarek, M. Warlich, A.W. Lohse, J.M. Pollok, A. Alexandrov, S. Urban, J. Petersen, and M. Lütgehetmann The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus J. Hepatol. 58 2013 861 867
7. A. Schieck, A. Schulze, C. Gähler, T. Müller, U. Haberkorn, A. Alexandrov, S. Urban, and W. Mier Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts Hepatology 58 2013 43 53
8. A. Schulze, A. Schieck, Y. Ni, W. Mier, and S. Urban Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction J. Virol. 84 2010 1989 2000
9. L.M. Ensign, R. Cone, and J. Hanes Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers Adv. Drug Deliv. Rev. 64 2012 557 570
10. M. Morishita, and N.A. Peppas Is the oral route possible for peptide and protein drug delivery? Drug Discovery Today 11 2006 905 910
11. R.H. Müller, K. MaÈder, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art Eur. J. Pharm. Biopharm. 50 2000 161 177
12. G. Fricker, T. Kromp, A. Wendel, A. Blume, J. Zirkel, H. Rebmann, C. Setzer, R.-O. Quinkert, F. Martin, and C. Müller-Goymann Phospholipids and lipid-based formulations in oral drug delivery Pharm. Res. 27 2010 1469 1486
13. G. Gaucher, P. Satturwar, M.-C. Jones, A. Furtos, and J.-C. Leroux Polymeric micelles for oral drug delivery Eur. J. Pharm. Biopharm. 76 2010 147 158
14. K. Gradauer, S. Dünnhaupt, C. Vonach, H. Szöllösi, I. Pali-Schöll, H. Mangge, E. Jensen-Jarolim, A. Bernkop-Schnürch, and R. Prassl Thiomer-coated liposomes harbor permeation enhancing and efflux pump inhibitory properties J. Control. Release 165 2013 207 215
15. K. Gradauer, J. Barthelmes, C. Vonach, G. Almer, H. Mangge, B. Teubl, E. Roblegg, S. Dünnhaupt, E. Fröhlich, and A. Bernkop-Schnürch Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats J. Control. Release 172 2013 872 878
16. M. Werle, and H. Takeuchi Chitosan-aprotinin coated liposomes for oral peptide delivery: development, characterisation and in vivo evaluation Int. J. Pharm. 370 2009 26 32
17. J. Parmentier, B. Thewes, F. Gropp, and G. Fricker Oral peptide delivery by tetraether lipid liposomes Int. J. Pharm. 415 2011 150 157
18. G. Mahmoud, J. Jedelská, B. Strehlow, and U. Bakowsky Bipolar tetraether lipids derived from thermoacidophilic archaeon Sulfolobus acidocaldarius for membrane stabilization of chlorin e6 based liposomes for photodynamic therapy Eur. J. Pharm. Biopharm. 95 2015 88 98
19. J. Parmentier, G. Hofhaus, S. Thomas, L.C. Cuesta, F. Gropp, R. Schröder, K. Hartmann, and G. Fricker Improved oral bioavailability of human growth hormone by a combination of liposomes containing bio-enhancers and tetraether lipids and omeprazole J. Pharm. Sci. 103 2014 3985 3993
20. S.M. Jensen, C.J. Christensen, J.M. Petersen, A.H. Treusch, and M. Brandl Liposomes containing lipids from Sulfolobus islandicus withstand intestinal bile salts: an approach for oral drug delivery? Int. J. Pharm. 493 2015 63 69
21. D. Crommelin, and E. Van Bommel Stability of liposomes on storage: freeze dried, frozen or as an aqueous dispersion Pharm. Res. 1 1984 159 163
22. K. Miyajima Role of saccharides for the freeze-thawing and freeze drying of liposome Adv. Drug Deliv. Rev. 24 1997 151 159
23. E.C. van Winden Freeze-drying of liposomes: theory and practice Methods Enzymol. 367 2003 99 110
24. S.V. Albers, W.N. Konings, A.J. Driessen, F. Rainey, and A. Oren Membranes of thermophiles and other extremophiles Meth. Microbiol. 35 2006 161 171
25. A. Schieck, T. Müller, A. Schulze, U. Haberkorn, S. Urban, and W. Mier Solid-phase synthesis of the lipopeptide Myr-HBVpreS/2-78, a hepatitis B virus entry inhibitor Molecules 15 2010 4773 4783
26. J.W. Crim, S.F. Garczynski, and M.R. Brown Approaches to radioiodination of insect neuropeptides Peptides 23 2002 2045 2051
27. M. Hirsch, V. Ziroli, M. Helm, and U. Massing Preparation of small amounts of sterile siRNA-liposomes with high entrapping efficiency by dual asymmetric centrifugation (DAC) J. Control. Release 135 2009 80 88
28. U. Massing, S. Cicko, and V. Ziroli Dual asymmetric centrifugation (DAC) - a new technique for liposome preparation J. Control. Release 125 2008 16 24
29. S.F. Pantze, J. Parmentier, G. Hofhaus, and G. Fricker Matrix liposomes: a solid liposomal formulation for oral administration Eur. J. Lipid Sci. Technol. 116 2014 1145 1154
30. M. Ausborn, H. Schreier, G. Brezesinski, H. Fabian, H.W. Meyer, and P. Nuhn The protective effect of free and membrane-bound cryoprotectants during freezing and freeze-drying of liposomes J. Control. Release 30 1994 105 116
31. D. Christensen, C. Foged, I. Rosenkrands, H.M. Nielsen, P. Andersen, and E.M. Agger Trehalose preserves DDA/TDB liposomes and their adjuvant effect during freeze-drying Biochim. Biophys. Acta (BBA) - Biomembr. 1768 2007 2120 2129
32. A.R. Mohammed, V.W. Bramwell, A.G. Coombes, and Y. Perrie Lyophilisation and sterilisation of liposomal vaccines to produce stable and sterile products Methods 40 2006 30 38
33. E.J.B. Nielsen, S. Yoshida, N. Kamei, R. Iwamae, E.-S. Khafagy, J. Olsen, U.L. Rahbek, B.L. Pedersen, K. Takayama, and M. Takeda-Morishita In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin J. Control. Release 189 2014 19 24